8legs: European congress on obesity

Your Followed Topics

#1 out of 40.00%

UK study shows GLP-1 weight-loss injections cut sick days by 45% over nine months.
Long-term absences dropped by more than half, easing NHS staffing pressures.
GP visits and in-person appointments declined as patients used digital care.
Experts say expanding access to anti-obesity meds could cut A&E visits by a quarter.
NHS could save about £364 million annually by widening jab eligibility.
Study involved 1,270 NHS patients on Oviva’s tier 3 weight-management programme.
Wegovy and Ozempic users achieved ~12.4% weight loss after nine months.
Danish studies linked GLP-1 use to fewer asthma exacerbations and migraine relief.
Researchers note the effects appear soon after starting GLP-1 therapy, even before weight loss.

Vote 0

#2 out of 40.00%

New analysis from a Norwegian study suggests rapid weight loss outperforms gradual loss in both short and longer terms.
Participants in the rapid plan followed a strict calorie schedule over 16 weeks, then entered a 36-week maintenance phase.
One-year results show the rapid group maintained greater weight loss than the gradual group.
Lead author Dr. Line Kristin Johnson says results challenge the belief that slow, gradual loss is necessary to prevent weight regain.
The study stresses supervision and professional guidance in achieving weight-loss goals.
The research questions existing assumptions about obesity treatment and long-term success.
Study included data from 284 obese adults across rapid and gradual programs.
The NHS is cited regarding daily caloric needs to contextualize weight loss goals.
The study was presented at the European Congress on Obesity in Turkey.
Researchers emphasize findings do not imply unsafe practices; supervision is key.

Vote 0

#3 out of 4

A European study proposes 8,500 steps a day, not 10,000, as the target during weight maintenance.
Researchers found no strong link between higher step counts and additional weight loss during the weight loss phase.
The study compared 1,987 patients in lifestyle programs with 1,771 controls.
The authors emphasize maintaining a higher step count during maintenance to prevent regain.
The European Congress on Obesity in Istanbul hosted the new step-count findings.
The analysis included measurements at multiple trial points: start, end of weight loss, and end of maintenance.
The headline takeaway: aim for 8,500 steps during weight loss and sustain into maintenance.
The source relays that the 10,000-step figure may have been overstated for most people.
The study supports step-count changes as a practical, affordable approach to weight stability.
The article frames the finding as a myth-busting update to common fitness advice.

Vote 0

#4 out of 4

New Swedish study links adult weight gain and higher starting weight with increased cancer risk across multiple cancers.
Study followed over 600,000 participants aged 17 to 60, with cancer diagnoses tracked until 2023.
Men who became obese before 30 saw up to five times higher risk for liver cancer and increased risk for several other cancers.
Women who developed obesity before 30 faced notably higher risks, including endometrial cancer.
Later weight gain showed gender differences, with women at higher risk for endometrial and postmenopausal breast cancers.
Among men, weight gains before 45 were linked to higher risks for esophageal and liver cancers.
Those who gained the most weight had higher overall cancer risk, including liver and colon cancers.
Women who gained the most weight had nearly four times the risk of endometrial cancer.
Even lower weight gains increased cancer risk, highlighting the need to maintain a healthy weight.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.